Backgrounds/Aims: This study attempted to identify risk factors for development of post-hepatectomy hepatic failure (PHF) and its effect on long-term survival of patients with liver metastases from colorectal cancer. Methods: We carried out a retrospective study of 143 patients who had been diagnosed with liver metastases from colorectal cancer and who had undergone hepatectomy between 2003 and 2010. We allocated these patients to PHF and non-PHF groups, using the definition of the International Study Group of Liver Surgery, and compared the clinical factors of the two groups, using Cox regression and Kaplan-Meier analysis to evaluate the differences in overall survival (OS) and recurrence-free survival (RFS) between these groups. Results: The PHF group comprised 19 patients (13.3%); all had Grade A PHF. Independent risk factors for development of PHF were metachronous liver metastases and major hepatectomy. The differences between the PHF and non-PHF groups in OS or RFS were not statistically significant; however, the PHF group tended to have a worse prognosis. Multivariate analysis revealed significant associations between OS and the factors of poor differentiation of the primary colorectal cancer, major hepatectomy, and positive resection margin. Conclusions: Major hepatectomy is an important risk factor for PHF in patients with liver metastases from colorectal cancer. The pathological characteristics of the primary tumor are more important as predictors than is Grade A PHF. (Ann Hepatobiliary Pancreat Surg 2018;22:93-100)
INTRODUCTION
Liver metastases are present in 14 to 25% of patients with colorectal cancer at the time of diagnosis and develop in about 60% of such patients during their lifetime. 1 Although most patients are not candidates for surgery, the optimal treatment for liver metastases is reportedly complete surgical resection, which achieves 5-year overall survival rates of 50%. 2, 3 Advances in preoperative chemotherapy and surgical techniques, such as portal vein ligation or embolization, have recently made more active surgical interventions possible for lesions that were previously considered unresectable. 4, 5 Post-hepatectomy hepatic failure (PHF), one of most feared and serious complications, is frequent, even though the prospects for survival and length of survival after liver resection have been improved. 6 Nevertheless, the clinical significance of PHF in patients with liver metastases from colorectal cancer has not been well examined.
In contrast, PHF in patients with hepatocellular carcinoma (HCC) has been well studied. Several studies reported that underlying liver disease, major hepatectomy, blood loss, and transfusion were risk factors for developing PHF. 7, 8 In addition, PHF in patients with HCC was significantly associated with postoperative complications and long-term survival. The mechanism by which PHF affects tumor progression or recurrence is unclear. One ex-planation is that PHF forces active regeneration of remnant liver, which could trigger growth of microscopic HCC and eventually cause recurrence of tumors after hepatectomy. 9 Thus, we assumed that PHF would increase tumor recurrence rates and reduce the survival time of patients with liver metastases from colorectal cancer. We therefore assessed the clinical significance of PHF in these patients by examining risk factors for development of PHF and its correlation with long-term survival. Table   2 ).
MATERIALS AND METHODS

Patients
Long-term outcome
The median duration of follow-up was 28 months (range 3-95). The 1-, 3-, and 5-year OS rates for all patients were 91.6%, 67.0%, and 56.7%, respectively, and 1-, 3-, and 5-year RFS rates 82.5%, 61.3%, and 56.8%, respectively. Long-term survival by study group is shown in Fig. 1 (Table 4) .
DISCUSSION
Regardless of the reason for liver resection, PHF is a predominant cause of postoperative morbidity and mortality after elective hepatic resection. 6, 12 Although survival rates after liver resection have improved during the past 10 years as a result of more accurate preoperative evaluation of hepatic functional reserve and of improvements in surgical techniques and perioperative management, 8, 13 PHF can still result from the underlying liver disease, functional hepatic reserve, or remnant liver volume.
14 Furthermore, PHF is clinically important because it decreases long-term survival and may prevent use of some treatment options for intrahepatic recurrence. 15 There have been many attempts to define PHF. First, Beaujon Hospital's team reported that a combination of prothrombin time of less than 50% and total bilirubin concentration of more than 50 mol/L (50-50 criteria) on postoperative day 5 predict mortality rate of more than 50% after liver resection. 16 Second, Mullen et al. 17 reported that peak serum bilirubin ＞7 mg/dl is the most powerful predictor of 90-day mortality after major hepatectomy. Finally, the ISGLS definition is characterized by an increased international normalized ratio and concomitant hyperbilirubinemia on or after postoperative day 5. 10 Skrzypczyk et al. 18 found that the ISGLS definition is less accurate than the other two criteria in identifying patients at risk of major complications or death after hepatectomy. However, despite its lower predictive value for early postoperative mortality, we chose to use the ISGLS definition in this study because it includes more patients whose PHF is less severe. We considered that such patients also need active regeneration of remnant liv- We next investigated whether PHF affects OS and RFS.
As shown in Fig. 1 , although the PHF group appeared to have lower OS and RFS, these differences were not statistically significant. Given that this was a retrospective study that may have had a selection bias, interpretation of the results requires particular care. Because major hepatectomy is a risk factor for development of both PHF and OS, enrollment of a larger number of patients could identify PHF as a significant risk factor for long-term outcomes. A study of 193 patients with liver metastases from colorectal cancer found that PHF did not affect the 3-month survival rate, but was associated with a worse 2-year survival. 22 The short follow-up period was also a limitation of our study.
We performed multivariate and Cox regression analysis to identify the risk factors for long-term survival and found that differentiation of the primary colorectal cancer is a significant risk factor for both OS and RFS. Previous studies have reported that poor differentiation of the primary tumor is an important factor affecting the survival of patients with liver metastases from colorectal cancer. 24 In our study, risk factors for OS also included major hepatectomy and positive resection margin, confirming that positive resection margin is an important prognostic factor for survival, as shown by others. 25 One limitation of this study concerns pre-hepatectomy chemotherapy. Previous studies have reported that preoperative chemotherapy that caused steatohepatitis or sinusoidal obstruction is associated with an increased incidence of post-hepatectomy complications. 26, 27 In our study, only 43 patients (30.0%) received pre-hepatectomy chemotherapy, which comprised oxaliplatin-based chemotherapy in 39 patients (90.6%) and irinotecan-based chemotherapy in two patients (4.6%). The lack of normal distribution of the data made it unsuitable for statistical analysis. Prehepatectomy chemotherapy did not seem to affect PHF, possibly because we could not perform subgroup analysis by type of chemotherapy. Furthermore, patients who had received pre-hepatectomy chemotherapy had worse RFS than those who did not. There are two possible ways of interpreting this result. First, our data was collected over a long period, during which the indications for chemotherapy changed. Second, a selection bias characterized by patients who received prehepatectomy chemotherapy and who tended to have more aggressive tumors may have influenced our findings.
In conclusion, we identified major hepatectomy as an independent risk factor for both developments of PHF and poor OS in patients with liver metastases from colorectal cancer. Tumor-related factors, such as differentiation of the primary tumor and size of metastasis, are more important factors for predicting length of survival than is occurrence of grade A PHF.
